Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -4,20k | 487,76k | Verkauf | 116,13 | 11,42k | -26,90% |
| 2026-05-21 | Mr. Hedi TliliPresident of Aptar Closures | -688,00 | 80,15k | Sale to Issuer | 116,50 | 24,23k | -2,76% |
| 2026-05-07 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -422,00 | 52,07k | Verkauf | 123,38 | 1,48k | -22,19% |
| 2026-05-07 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -842,00 | 10,16k | Derivative Exercise and Sale | 111,38 - 123,45 | 1,48k | - |
| 2026-05-01 | Mr. Hedi TliliPresident of Aptar Closures | -3,60k | 457,70k | Sale to Issuer | 127,21 | 24,92k | -12,62% |
| 2026-05-01 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -2,56k | 304,57k | Sale to Issuer | 119,02 | 15,62k | -14,08% |
| 2026-05-01 | Mr. Gael TouyaPresident of Aptar Pharma | -4,18k | 531,10k | Sale to Issuer | 127,21 | 32,84k | -11,28% |
| 2026-05-01 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -247,00 | 29,40k | Sale to Issuer | 119,02 | 1,90k | -11,49% |
| 2026-05-01 | Ms. Shiela Pallerne VinczellerChief HR Officer | -2,15k | 255,89k | Sale to Issuer | 119,02 | 30,63k | -6,56% |
| 2026-05-01 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -15,54k | 1,85M | Sale to Issuer | 119,02 | 241,87k | -6,04% |
| 2026-03-17 | Mr. Hedi TliliPresident of Aptar Closures | -273,00 | 35,48k | Sale to Issuer | 129,97 | 8,36k | -3,16% |
| 2026-03-17 | Mr. Gael TouyaPresident of Aptar Pharma | -320,00 | 41,59k | Sale to Issuer | 129,97 | 27,29k | -1,16% |
| 2026-03-17 | Ms. Mahawa Vanessa TourayInsider | -368,00 | 47,66k | Sale to Issuer | 129,50 | 9,35k | -3,79% |
| 2026-03-17 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -213,00 | 27,58k | Sale to Issuer | 129,50 | 9,74k | -2,14% |
| 2026-03-17 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -37,00 | 4,79k | Sale to Issuer | 129,50 | 689,00 | -5,10% |
| 2026-03-17 | Ms. Shiela Pallerne VinczellerChief HR Officer | -139,00 | 18,00k | Sale to Issuer | 129,50 | 25,06k | -0,55% |
| 2026-03-17 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -1,77k | 229,47k | Sale to Issuer | 129,50 | 204,12k | -0,86% |
| 2026-03-16 | Mr. Gael TouyaPresident of Aptar Pharma | -791,00 | 102,42k | Sale to Issuer | 129,48 | 27,61k | -2,78% |
| 2026-03-16 | Mr. Hedi TliliPresident of Aptar Closures | -677,00 | 87,66k | Sale to Issuer | 129,48 | 8,64k | -7,27% |
| 2026-03-15 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -3,46k | 444,49k | Sale to Issuer | 128,65 | 205,90k | -1,65% |
| 2026-03-15 | Ms. Shiela Pallerne VinczellerChief HR Officer | -333,00 | 42,84k | Sale to Issuer | 128,65 | 25,20k | -1,30% |
| 2026-03-15 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -481,00 | 61,88k | Sale to Issuer | 128,65 | 9,96k | -4,61% |
| 2026-03-15 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -72,00 | 9,26k | Sale to Issuer | 128,65 | 726,00 | -9,02% |
| 2026-03-02 | Mr. Gael TouyaPresident of Aptar Pharma | -335,00 | 47,91k | Sale to Issuer | 143,00 | 28,41k | -1,17% |
| 2026-02-27 | Mr. Hedi TliliPresident of Aptar Closures | -66,00 | 9,34k | Sale to Issuer | 141,53 | 9,31k | -0,70% |
| 2026-02-27 | Mr. Gael TouyaPresident of Aptar Pharma | -348,00 | 49,25k | Sale to Issuer | 141,53 | 28,74k | -1,20% |
| 2026-02-25 | Ms. Shiela Pallerne VinczellerChief HR Officer | -96,00 | 13,70k | Sale to Issuer | 142,68 | 25,53k | -0,37% |
| 2026-02-25 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -940,00 | 134,12k | Sale to Issuer | 142,68 | 209,35k | -0,45% |
| 2026-02-24 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -291,00 | 41,94k | Sale to Issuer | 144,14 | 10,37k | -2,73% |
| 2026-02-24 | Ms. Shiela Pallerne VinczellerChief HR Officer | -219,00 | 31,57k | Sale to Issuer | 144,14 | 24,75k | -0,88% |
| 2026-02-24 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -1,32k | 190,41k | Sale to Issuer | 144,14 | 205,81k | -0,64% |
| 2026-02-23 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -180,00 | 26,23k | Sale to Issuer | 145,72 | 10,66k | -1,66% |
| 2026-02-23 | Ms. Shiela Pallerne VinczellerChief HR Officer | -168,00 | 24,48k | Sale to Issuer | 145,72 | 24,97k | -0,67% |
| 2026-02-23 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -987,00 | 143,83k | Sale to Issuer | 145,72 | 207,13k | -0,47% |
| 2026-02-18 | Mr. Gael TouyaPresident of Aptar Pharma | -3,50k | 494,74k | Verkauf | 141,35 | 27,96k | -11,12% |
| 2026-02-10 | Mr. Marc PrieurPresident of Aptar Beauty | -2,00k | 275,62k | Verkauf | 137,81 | 13,75k | -12,70% |
| 2025-12-12 | Mr. Daniel Richard AckermanSenior VP, Principal Accounting Officer & CAO | -15,00k | 751,64k | Derivative Exercise and Sale | 71,12 - 121,23 | 29,61k | - |
| 2025-09-11 | Mr. Gael TouyaPresident of Aptar Pharma | -2,50k | 340,30k | Verkauf | 136,05 - 136,13 | 31,46k | -7,36% |
| 2025-09-05 | Ms. Shiela Pallerne VinczellerChief HR Officer | -1,17k | 161,01k | Verkauf | 137,97 | 25,13k | -4,44% |
| 2025-06-13 | Mr. Marc PrieurPresident of Aptar Beauty | -2,00k | 305,61k | Verkauf | 152,80 | 15,75k | -11,27% |
| 2025-06-10 | Ms. Kimberly Y. ChaineyInsider | -1,67k | 255,32k | Verkauf | 152,79 | 11,09k | -13,10% |
| 2025-06-06 | Mr. Gael TouyaPresident of Aptar Pharma | -3,30k | 503,65k | Verkauf | 152,50 - 153,88 | 33,96k | -8,86% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
